 |
5 Diseases |  |
67 Trials |
|
67 Trials |  |
4266 News |  |
| «12...52535455565758596061626364 |
- Trial initiation date: Antipsychotic Discontinuation in Alzheimer's Disease (clinicaltrials.gov) - Dec 1, 2011
P4, N=180, Completed, Sponsor: New York State Psychiatric Institute
Initiation date: Jan 2004 --> Aug 2004
- | Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
New P4 trial: Brain Myelination Effects of Paliperidone Palmitate Versus Oral Risperidone in First Episode Schizophrenia (clinicaltrials.gov) - Oct 20, 2011
P4, N=50, Not yet recruiting, Sponsor: University of California, Los Angeles
- | Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
New P4 trial: Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia (clinicaltrials.gov) - Oct 12, 2011
P4, N=170, Recruiting, Sponsor: University of California, Los Angeles
- ||||| risperidone / Generic mfg.
New P2 trial: POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia (clinicaltrials.gov) - Oct 10, 2011
P2, N=60, Recruiting, Sponsor: PharmaNeuroBoost N.V.
- |||| risperidone / Generic mfg.
Trial completion, Adverse events: A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children (clinicaltrials.gov) - Oct 10, 2011
P4, N=244, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Initiation date: Jan 2004 --> Aug 2004 Recruiting --> Completed
- Clopixol (zuclopenthixol) / Lundbeck
Trial completion, Adverse events: Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia (clinicaltrials.gov) - Sep 15, 2011
P=N/A, N=56, Completed, Sponsor: Birte Glenthoj
Recruiting --> Completed No longer recruiting --> Completed
- aripiprazole / Generic mfg., risperidone / Generic mfg.
Biomarker, Enrollment open: Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) (clinicaltrials.gov) - Aug 29, 2011
P=N/A, N=250, Recruiting, Sponsor: Medical University of South Carolina
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- ||||||| lurasidone / Generic mfg.
Trial completion: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia (clinicaltrials.gov) - Aug 15, 2011
P3, N=629, Completed, Sponsor: Sunovion
Not yet recruiting --> Recruiting Active, not recruiting --> Completed